Evidence map›Paper›PMID 34611233›Full record

ArticleScientific reports2021

Corneal nerve loss as a surrogate marker for poor pial collaterals in patients with acute ischemic stroke.

Adnan Khan, Ajay Menon, Naveed Akhtar, Saadat Kamran, Ahmad Muhammad, Georgios Ponirakis, Hoda Gad, Ioannis N Petropoulos, Faisal Wadiwala, Blessy Babu and 9 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Adnan KhanWeill Cornell Medicine-Qatar, Doha, Qatar.
Ajay MenonWeill Cornell Medicine-Qatar, Doha, Qatar.
Naveed AkhtarInstitute of Neuroscience, Hamad Medical Corporation, Doha, Qatar.
Saadat KamranInstitute of Neuroscience, Hamad Medical Corporation, Doha, Qatar.
Ahmad MuhammadInstitute of Neuroscience, Hamad Medical Corporation, Doha, Qatar.
Georgios PonirakisWeill Cornell Medicine-Qatar, Doha, Qatar.
Hoda GadWeill Cornell Medicine-Qatar, Doha, Qatar.
Ioannis N PetropoulosWeill Cornell Medicine-Qatar, Doha, Qatar.
Faisal WadiwalaInstitute of Neuroscience, Hamad Medical Corporation, Doha, Qatar.
Blessy BabuInstitute of Neuroscience, Hamad Medical Corporation, Doha, Qatar.
Adeeb M NarangoliWeill Cornell Medicine-Qatar, Doha, Qatar.
Pablo G BermejoDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, Australia.
Hanadi Al HamadGeriatric, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Marwan RamadanGeriatric, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Peter WoodruffPsychiatry Hospital, Hamad Medical Corporation, Doha, Qatar.
Mark SantosInstitute of Neuroscience, Hamad Medical Corporation, Doha, Qatar.
Maher SaqqurTrillium Hospital, University of Toronto at Mississauga, Mississauga, ON, Canada.
Ashfaq ShuaibDepartment of Medicine, University of Alberta, Alberta, Canada.
Rayaz A MalikWeill Cornell Medicine-Qatar, Doha, Qatar. ram2045@qatar-med.cornell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In patients with acute ischemic stroke, pial collaterals play a key role in limiting neurological disability by maintaining blood flow to ischemic penumbra. We hypothesized that patient with poor pial collaterals will have greater corneal nerve and endothelial cell abnormalities. In a cross-sectional study, 35 patients with acute ischemic stroke secondary to middle cerebral artery (MCA) occlusion with poor (n = 12) and moderate-good (n = 23) pial collaterals and 35 healthy controls underwent corneal confocal microscopy and quantification of corneal nerve and endothelial cell morphology. In patients with MCA stroke, corneal nerve fibre length (CNFL) (P < 0.001), corneal nerve fibre density (CNFD) (P = 0.025) and corneal nerve branch density (CNBD) (P = 0.002) were lower compared to controls. Age, BMI, cholesterol, triglycerides, HDL, LDL, systolic blood pressure, NIHSS and endothelial cell parameters did not differ but mRS was higher (p = 0.023) and CNFL (p = 0.026) and CNBD (p = 0.044) were lower in patients with poor compared to moderate-good collaterals. CNFL and CNBD distinguished subjects with poor from moderate-good pial collaterals with an AUC of 72% (95% CI 53-92%) and 71% (95% CI 53-90%), respectively. Corneal nerve loss is greater in patients with poor compared to moderate-good pial collaterals and may act as a surrogate marker for pial collateral status in patients with ischemic stroke.

Indexed as

BiomarkersCerebrovascular CirculationCollateral CirculationAdultAgedCase-Control StudiesCorneaEndothelial CellsFemaleHumansIschemic StrokeMaleMicroscopy, ConfocalMiddle AgedReproducibility of ResultsBiomarkers

Identifiers

PMID34611233
PMCPMC8492683

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.